WO2012004811A8 - Process for the preparation of 5-substsituted indole derivative - Google Patents
Process for the preparation of 5-substsituted indole derivative Download PDFInfo
- Publication number
- WO2012004811A8 WO2012004811A8 PCT/IN2011/000447 IN2011000447W WO2012004811A8 WO 2012004811 A8 WO2012004811 A8 WO 2012004811A8 IN 2011000447 W IN2011000447 W IN 2011000447W WO 2012004811 A8 WO2012004811 A8 WO 2012004811A8
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- preparation
- formula
- eletriptan
- relates
- present
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Ceased
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
- C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
- C07D403/06—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Indole Compounds (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
The present invention relates to an improved and industrially advantageous process for preparation of eletriptan of formula I, or pharmaceutically acceptable salts thereof from bromo indole intermediate of formula II, through isolation of N-acetylated bromo indole intermediate of formula III, to elude carrying forward of impurities to next stage. The present invention relates to process for the preparation of 5-bromo-3-[(R)-1-methyl-pyrrolidin-2-ylmethyl]-1H-indol of formula II, a key intermediate for the synthesis of eletriptan or pharmaceutically acceptable salts thereof, through novel keto carbamate intermediate. The present invention also relates to novel process for the preparation of α-form of eletriptan hydrobromide.
Applications Claiming Priority (4)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| IN1580/DEL/2010 | 2010-07-06 | ||
| IN1580DE2010 | 2010-07-06 | ||
| IN1469/DEL/2011 | 2011-05-23 | ||
| IN1469DE2011 | 2011-05-23 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| WO2012004811A1 WO2012004811A1 (en) | 2012-01-12 |
| WO2012004811A8 true WO2012004811A8 (en) | 2012-08-09 |
Family
ID=45440827
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PCT/IN2011/000447 Ceased WO2012004811A1 (en) | 2010-07-06 | 2011-07-04 | Process for the preparation of 5-substsituted indole derivative |
Country Status (1)
| Country | Link |
|---|---|
| WO (1) | WO2012004811A1 (en) |
Families Citing this family (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2014063752A1 (en) | 2012-10-26 | 2014-05-01 | Synthon Bv | Process for making crystalline form alpha of eletriptan hydrobromide |
| EP2953972B1 (en) | 2013-02-05 | 2020-07-08 | EngMab Sàrl | Method for the selection of antibodies against bcma |
| CN104292217A (en) * | 2013-04-08 | 2015-01-21 | 上海医药工业研究院 | Preparation method and purification method of alpha crystal form eletriptan hydrobromide |
| CN104230895B (en) * | 2013-06-08 | 2017-02-08 | 上海医药工业研究院 | Preparation method for eletriptan intermediate |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB9208161D0 (en) * | 1992-04-14 | 1992-05-27 | Pfizer Ltd | Indoles |
| GB0031094D0 (en) * | 2000-12-20 | 2001-01-31 | Pfizer Ltd | New Process |
| GB0317229D0 (en) * | 2003-07-23 | 2003-08-27 | Pfizer Ltd | Improved process |
-
2011
- 2011-07-04 WO PCT/IN2011/000447 patent/WO2012004811A1/en not_active Ceased
Also Published As
| Publication number | Publication date |
|---|---|
| WO2012004811A1 (en) | 2012-01-12 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| WO2011015522A3 (en) | Process for the manufacture of pharmaceutically active compounds | |
| WO2012015681A3 (en) | Drug-ligand conjugates, synthesis thereof, and intermediates thereto | |
| WO2010048477A3 (en) | Improved process for preparation of coupled products from 4-amino-3-cyanoquinolines using stabilized intermediates | |
| WO2012042534A3 (en) | Preparation of r-sitagliptin and intermediates thereof | |
| WO2011123947A8 (en) | Synthesis of chiral 2-(1h-indazol-6-yl)-spiro[cyclopropane-1,3'- indolin]-2'-ones | |
| WO2011022596A3 (en) | Preparation of bazedoxifene and its salts | |
| GEP20125491B (en) | New process for the synthesis of ivabradine and addition salts thereof with a pharmaceutically acceptable acid | |
| WO2010140765A3 (en) | Novel method for preparing rosuvastatin, intermediate compounds useful for preparing same, and method for preparing same | |
| WO2008096372A3 (en) | Process for preparing highly pure ezetimibe using novel intermediates | |
| WO2010076810A3 (en) | A process for the preparation of gefitinib | |
| MX2011007978A (en) | Novel method for the synthesis of ivabradine and the pharmaceutically acceptable acid addition salts thereof. | |
| WO2009116074A3 (en) | Substituted benzimidazoles as cannabinoid modulator | |
| WO2006113509A3 (en) | Quinobenzoxazine analogs and methods of using thereof | |
| WO2009047499A3 (en) | Processes for the preparation of paliperidone and pharmaceutically acceptable salts thereof and intermediates for use in the processes | |
| WO2012004811A8 (en) | Process for the preparation of 5-substsituted indole derivative | |
| IN2012DN04868A (en) | ||
| MX2012002818A (en) | Novel method for synthesizing ivabradine and the addition salts thereof with a pharmaceutically acceptable acid. | |
| WO2010083996A8 (en) | A process for preparing memantine | |
| MX2010009926A (en) | New process for the preparatiion of cyclohexanecarboxylic acid dericatives. | |
| WO2009075516A3 (en) | Process for preparing pantoprazole sodium sesquihydrate | |
| WO2009021943A3 (en) | Novel preparation process | |
| WO2012015687A3 (en) | Drug-ligand conjugates, synthesis thereof, and intermediates thereto | |
| WO2008059513A3 (en) | Compounds suitable as modulators of hdl | |
| WO2010122580A3 (en) | Piperidine derivatives as inhibitors of renin | |
| WO2010004580A3 (en) | Process for preparing indole derivatives |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| 121 | Ep: the epo has been informed by wipo that ep was designated in this application |
Ref document number: 11803244 Country of ref document: EP Kind code of ref document: A1 |
|
| NENP | Non-entry into the national phase in: |
Ref country code: DE |
|
| 122 | Ep: pct app. not ent. europ. phase |
Ref document number: 11803244 Country of ref document: EP Kind code of ref document: A1 |